JP2009519013A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519013A5 JP2009519013A5 JP2008543714A JP2008543714A JP2009519013A5 JP 2009519013 A5 JP2009519013 A5 JP 2009519013A5 JP 2008543714 A JP2008543714 A JP 2008543714A JP 2008543714 A JP2008543714 A JP 2008543714A JP 2009519013 A5 JP2009519013 A5 JP 2009519013A5
- Authority
- JP
- Japan
- Prior art keywords
- egfr
- binding polypeptide
- polypeptide according
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000001301 EGF receptor Human genes 0.000 claims 73
- 108060006698 EGF receptor Proteins 0.000 claims 73
- 229920001184 polypeptide Polymers 0.000 claims 65
- 102000004196 processed proteins & peptides Human genes 0.000 claims 65
- 108090000765 processed proteins & peptides Proteins 0.000 claims 65
- 125000003275 alpha amino acid group Chemical group 0.000 claims 18
- 238000001514 detection method Methods 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 4
- 108020001580 protein domains Proteins 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000000032 diagnostic agent Substances 0.000 claims 3
- 229940039227 diagnostic agent Drugs 0.000 claims 3
- 230000003993 interaction Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 230000005855 radiation Effects 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 238000003384 imaging method Methods 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 239000012857 radioactive material Substances 0.000 claims 2
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 1
- 108700011201 Streptococcus IgG Fc-binding Proteins 0.000 claims 1
- 208000005221 X-linked episodic muscle weakness Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 239000012216 imaging agent Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0524788.7 | 2005-12-05 | ||
| GBGB0524788.7A GB0524788D0 (en) | 2005-12-05 | 2005-12-05 | Polypeptides |
| PCT/EP2006/011669 WO2007065635A1 (en) | 2005-12-05 | 2006-12-05 | Polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013270874A Division JP2014087361A (ja) | 2005-12-05 | 2013-12-27 | ポリペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009519013A JP2009519013A (ja) | 2009-05-14 |
| JP2009519013A5 true JP2009519013A5 (cg-RX-API-DMAC10.html) | 2010-01-28 |
| JP5898826B2 JP5898826B2 (ja) | 2016-04-06 |
Family
ID=35686099
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008543714A Expired - Fee Related JP5898826B2 (ja) | 2005-12-05 | 2006-12-05 | ポリペプチド |
| JP2013270874A Pending JP2014087361A (ja) | 2005-12-05 | 2013-12-27 | ポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013270874A Pending JP2014087361A (ja) | 2005-12-05 | 2013-12-27 | ポリペプチド |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8247375B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP1973934B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP5898826B2 (cg-RX-API-DMAC10.html) |
| CN (2) | CN101336250A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2631430C (cg-RX-API-DMAC10.html) |
| DK (1) | DK2431383T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2599996T3 (cg-RX-API-DMAC10.html) |
| GB (1) | GB0524788D0 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2007065635A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2077272A1 (en) | 2007-12-21 | 2009-07-08 | Affibody AB | Polypeptide libraries with a predetermined scaffold |
| US9187535B2 (en) | 2007-12-19 | 2015-11-17 | Affibody Ab | Polypeptide derived from protein A and able to bind PDGF |
| EP2072525A1 (en) * | 2007-12-21 | 2009-06-24 | Affibody AB | New polypeptides having affinity for HER2 |
| EA021967B1 (ru) * | 2008-01-03 | 2015-10-30 | Дзе Скриппс Рисерч Инститьют | Доставка антител посредством модульного домена распознавания |
| US9238810B2 (en) | 2008-06-05 | 2016-01-19 | Affibody Ab | Polypeptide |
| KR101671537B1 (ko) | 2008-08-11 | 2016-11-01 | 넥타르 테라퓨틱스 | 다분지형 중합체 알카노에이트 컨쥬게이트 |
| US20120165650A1 (en) | 2010-12-22 | 2012-06-28 | General Electric Company | Her2 binders |
| EP2496598B1 (en) | 2009-11-04 | 2017-08-02 | Affibody AB | Her3 binding polypeptides |
| MX349054B (es) | 2010-09-28 | 2017-07-07 | Aegerion Pharmaceuticals Inc | Leptinas altamente solubles. |
| US10894087B2 (en) | 2010-12-22 | 2021-01-19 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
| US20130331443A1 (en) | 2010-12-22 | 2013-12-12 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
| DK2714738T3 (en) | 2011-05-24 | 2019-01-28 | Zyngenia Inc | MULTIVALENT AND MONOVALENT MULTISPECIFIC COMPLEXES AND THEIR APPLICATIONS |
| WO2012166555A1 (en) | 2011-05-27 | 2012-12-06 | Nektar Therapeutics | Water - soluble polymer - linked binding moiety and drug compounds |
| EP2728000B1 (en) * | 2011-06-03 | 2018-12-05 | National Institute of Advanced Industrial Science And Technology | Protein a mutant protein having reduced affinity in acidic region, and antibody capture agent |
| DK2729160T3 (da) | 2011-07-08 | 2019-07-01 | Aegerion Pharmaceuticals Inc | Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet |
| TWI443108B (zh) | 2011-12-28 | 2014-07-01 | Ind Tech Res Inst | 抗人類表皮生長因子受體抗體及其應用 |
| KR102149028B1 (ko) | 2012-02-20 | 2020-08-27 | 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) | 인간 보체 c5에 결합하는 폴리펩티드 |
| WO2014013016A1 (en) | 2012-07-20 | 2014-01-23 | Affibody Ab | Method for determining the her2 status of a malignancy |
| WO2014053586A1 (en) | 2012-10-05 | 2014-04-10 | Affibody Ab | Her3 binding polypeptides |
| CN111363047A (zh) | 2013-03-12 | 2020-07-03 | 分子模板公司 | 用于引起细胞内化的cd20结合免疫毒素及其使用方法 |
| ES2749862T3 (es) | 2014-01-27 | 2020-03-24 | Molecular Templates Inc | Polipéptidos efectores desinmunizados de subunidad A de toxina Shiga para aplicaciones en mamíferos |
| ES2864124T3 (es) | 2014-03-11 | 2021-10-13 | Molecular Templates Inc | Proteínas que comprenden regiones de unión, regiones efectoras de la subunidad A de toxina Shiga y motivos señal de localización de retículo endoplasmático carboxi terminal |
| PT3604333T (pt) | 2014-03-11 | 2021-06-07 | Molecular Templates Inc | Proteínas compreendendo regiões efetoras da subunidade a da toxina shiga próximas de amino-terminais e regiões de ligação do tipo imunoglobulina de direcionamento celular capazes de se ligarem especificamente a cd38 |
| KR102496206B1 (ko) | 2014-06-11 | 2023-02-06 | 몰레큘러 템플레이츠, 인코퍼레이션. | 프로테아제-절단 저항성의 시가 독소 a 서브유닛 작동체 폴리펩티드 및 이를 포함하는 세포-표적화 분자 |
| PL3212225T3 (pl) | 2014-10-31 | 2026-03-30 | The Trustees Of The University Of Pennsylvania | Sposoby i kompozycje zmodyfikowanych limfocytów t |
| KR20240110106A (ko) | 2015-01-12 | 2024-07-12 | 애피바디 에이비 | Il-17a-결합 폴리펩티드 |
| MX2018001208A (es) | 2015-07-26 | 2018-03-26 | Molecular Templates Inc | Moleculas con direccion a las celulas que comprenden efectores de la subunidad a de la toxina shiga y epitopos de celulas-t cd8+. |
| US10521754B2 (en) * | 2016-03-08 | 2019-12-31 | Auctane, LLC | Concatenated shipping documentation processing spawning intelligent generation subprocesses |
| CN111925425B (zh) * | 2020-08-12 | 2023-03-10 | 天津科技大学 | 甲胎蛋白特异性结合多肽及应用 |
| JP2025507294A (ja) * | 2022-02-04 | 2025-03-18 | ザイトックス セラピューティクス アクチボラゲット | Ｅｇｆｒ結合ドメインとマスキングドメインとを含む融合タンパク質 |
| CN119677787A (zh) | 2022-08-10 | 2025-03-21 | 兴和株式会社 | 亲和体微胞药物复合体 |
| CN117106035B (zh) * | 2023-10-25 | 2024-04-23 | 烟台药物研究所 | 一种肿瘤靶向多肽、多肽偶联药物及制备与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9400088D0 (sv) | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| SE9901379D0 (sv) * | 1999-04-19 | 1999-04-19 | Pharmacia & Upjohn Ab | Receptor structures |
| GB0017720D0 (en) | 2000-07-19 | 2000-09-06 | Got A Gene Ab | Modified virus |
| SE0301936D0 (sv) | 2003-06-30 | 2003-06-30 | Affibody Ab | New polypeptide |
| CA2531238C (en) * | 2003-07-04 | 2015-02-24 | Affibody Ab | Polypeptides having binding affinity for her2 |
| SE0400274D0 (sv) * | 2004-02-09 | 2004-02-09 | Affibody Ab | New polypeptide |
| JPWO2005095419A1 (ja) | 2004-04-01 | 2008-02-21 | 武田薬品工業株式会社 | チアゾロピリミジン誘導体 |
| US8642743B2 (en) | 2004-04-06 | 2014-02-04 | Affibody Ab | Method for reducing the immune response to a biologically active protein |
| AU2005233843A1 (en) * | 2004-04-16 | 2005-10-27 | Hidetoshi Okabe | Method of examining malignant tumor |
-
2005
- 2005-12-05 GB GBGB0524788.7A patent/GB0524788D0/en not_active Ceased
-
2006
- 2006-12-05 EP EP06829313.3A patent/EP1973934B1/en active Active
- 2006-12-05 CA CA2631430A patent/CA2631430C/en active Active
- 2006-12-05 EP EP11194071.4A patent/EP2431383B1/en active Active
- 2006-12-05 CN CNA2006800523510A patent/CN101336250A/zh active Pending
- 2006-12-05 DK DK11194071.4T patent/DK2431383T3/en active
- 2006-12-05 CN CN201310114471.0A patent/CN103288935B/zh not_active Expired - Fee Related
- 2006-12-05 JP JP2008543714A patent/JP5898826B2/ja not_active Expired - Fee Related
- 2006-12-05 ES ES11194071.4T patent/ES2599996T3/es active Active
- 2006-12-05 WO PCT/EP2006/011669 patent/WO2007065635A1/en not_active Ceased
- 2006-12-05 US US12/085,576 patent/US8247375B2/en active Active
-
2012
- 2012-07-16 US US13/549,588 patent/US8598113B2/en active Active
-
2013
- 2013-10-16 US US14/055,443 patent/US9107965B2/en active Active
- 2013-12-27 JP JP2013270874A patent/JP2014087361A/ja active Pending